This award supports early-career research focused on invasive lobular carcinoma (ILC), the second most common histologic subtype of breast cancer. AACR states that proposed work may be basic, translational, clinical, epidemiological, population health, or community-based, as long as it is directly relevant to ILC. The application is open now and closes April 7, 2026.
Eligibility Criteria:
- Applicants must hold a doctoral degree such as PhD, MD, MD/PhD, or equivalent.
- At the start of the grant term, applicants must hold a faculty appointment such as assistant professor, instructor, research assistant professor, or equivalent.
- The proposed research must be directly applicable to invasive lobular carcinoma (ILC).
Funding Details:
- Amount: $150,000 USD.
- Grant term: 2 years.
- Indirect costs: up to 5% of the total grant may be used if mandated by the institution.
Deadline:
- Application deadline: April 7, 2026 at 1:00 PM ET.
- Decision date: June 2026.
- Start of grant term: July 1, 2026.
Where to go for further information:
- Program page: BCRF and LBCA-AACR Career Development Award
- Contact: grants@aacr.org.